ProMIS Neurosciences, Inc. ( PMN) - Key Metrics
PMN Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q2 | $0 | -$1.28 | -$1.14 | -$1.14 |
| 2026Q1 | $0 | -$1.26 | -$1.90 | -$1.90 |
| 2025Q4 | $0 | -$6.08 | -$5.15 | -$5.15 |
| 2025Q3 | $0 | -$8.31 | -$7.30 | -$7.30 |
| 2025Q2 | $0 | -$7.26 | -$2.76 | -$2.76 |
PMN Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q2 | 0% | -2.57 |
| 2026Q1 | 0% | -2.52 |
| 2025Q4 | 0% | -0.25 |
| 2025Q3 | 0% | -0.32 |
| 2025Q2 | 0% | -0.42 |
PMN
Price: $8.15
52 week price:
Earnings Per Share: -12.62 USD
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Market Capitalization: 84.0 million